Nakawa, a trusted weight loss physician in Lake County, providing expert, personalized guidance tailored to your health needs and goals
Over the four-year period, the percentage of female patients with a semaglutide or tirzepatide prescription who also had PCOS increased from 4.6% in 2021 to 5.7% in 2025, representing a 23.9% relative increase
Administration is described below the skin, not attempting to reach deeper into the muscle or vein
The key shift is from a single pathway to a network: no longer one receptor, but the integration of entero-pancreatic signals acting in a coordinated way on brain, liver, muscle, and adipose tissue
While this practice is regulated, the FDA does not review compounded semaglutide for its safety and effectiveness